drugset / Trial / NCT00924586
Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Landiolol | Small molecule | 0.125 mg/kg | Intravenous |